US Food and Drug Administration
The US Food and Drug Administration (FDA) has said the Pfizer COVID vaccine is safe and effective in children under five, ahead of a meeting to weigh its authorization later this week.Children under five are the only age group not yet eligible for vaccination in the United States (US) and most countries, a pressing need since rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age," the FDA said in a document posted on its website Sunday.
United States (US) biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its COVID vaccine in children under six years old after the two-shot regimen was found to be safe and produced a strong immune response.Specifically, two doses of 25 micrograms given to babies, toddlers and pre-schoolers generated similar levels of antibodies to two doses of 100 micrograms given to young people aged 18-25, indicating there would be similar levels of protection.Children under six
The United States (US) Food and Drug Administration (FDA) updated its warning labels Monday for the Johnson & Johnson COVID-19 vaccine to include information about an observed "increased risk" of a rare neurological disorder called Guillain-Barre Syndrome (GBS).The news is a further blow for the company, which was granted an emergency use authorisation for its shot in February but has played a minor role in America's coronavirus immunisation campaign.Based on analysis o
As several vaccines are rolled out across the world, questions already resolved in the lab are cropping up once again, as governments face the challenges of delivering the jabs to millions of people.
United States (US) giant Pfizer and its German partner BioNTech confirmed they would seek approval on Friday to roll out their coronavirus vaccine early as surging infections forced New York to shut schools and California braced for night-time curfews.The world is looking to scientists for salvation from the global pandemic but a second wave of infections is prompting a return to the shutdowns and closures that traumatised nations and upturned the global economy at the start of the year.The f
The sweltering backwaters of Indonesian Borneo have become the unlikely ground zero for the global production and export of Kratom, a tree leaf hailed by some as a miracle cure for everything from opioid addiction to anxiety.Part of the coffee family, the leaf has been used for centuries in Southeast Asia and Papua New Guinea for its pain-relieving and mildly stimulating effects but it is now sold in powder form and exported worldwide – alarming some health regulators who have raised concerns
